Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli

Dhundy R Bastola1, Gurcharan S Pahwa, Ming-Fong Lin

  • 1Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha 68198-4525, USA.

Insights

The tumor suppressor gene PTEN is crucial in prostate cancer. This study developed an antibody to detect PTEN, finding its expression impacts cell signaling pathways like PKB/Akt.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • PTEN (Phosphatase and tensin homolog) is a tumor suppressor gene frequently altered in human cancers, including prostate cancer.
  • Understanding PTEN expression is vital for elucidating prostate cancer development and progression.

Purpose of the Study:

  • To develop a monoclonal antibody for detecting human PTEN.
  • To investigate PTEN gene and protein expression in human prostate cancer cell lines.
  • To explore the relationship between PTEN expression and cellular signaling pathways.

Main Methods:

  • Production of a monoclonal antibody against recombinant human PTEN.
  • Northern blotting to analyze PTEN mRNA expression in PC-3, LNCaP, and DU 145 cell lines.
  • Western blotting using the developed antibody to detect PTEN protein expression.
  • Analysis of PKB/Akt phosphorylation levels in relation to PTEN expression.

Main Results:

  • PTEN mRNA was detected in LNCaP and DU 145 cells, but not in PC-3 cells.
  • PTEN protein was expressed in DU 145 cells but not in LNCaP cells.
  • In DU 145 cells, PTEN expression inversely correlated with serum concentration and PKB/Akt phosphorylation.
  • Prostate cancer cells lacking PTEN exhibited higher basal PKB/Akt activity compared to those expressing wild-type PTEN.

Conclusions:

  • PTEN plays a significant role in regulating cellular signaling pathways within prostate cancer cells.
  • The developed monoclonal antibody is a valuable tool for studying PTEN expression.
  • Differential PTEN expression contributes to varying cellular signaling activities in prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...